(0.10%) 5 522.25 points
(0.14%) 39 898 points
(0.20%) 19 791 points
(-0.06%) $81.58
(0.57%) $2.83
(-0.23%) $2 339.00
(0.15%) $29.57
(0.45%) $1 006.30
(0.05%) $0.932
(-0.02%) $10.53
(0.02%) $0.788
(-0.85%) $87.25
0.00% $ 1.480
Live Chart Being Loaded With Signals
TCR2 Therapeutics Inc., a clinical-stage immunotherapy company, focuses on developing novel T cell receptor (TCR) therapies for patients suffering from cancer...
Stats | |
---|---|
Dzisiejszy wolumen | 3.75M |
Średni wolumen | 325 040 |
Kapitalizacja rynkowa | 58.11M |
EPS | $-1.030 ( Q1 | 2023-05-11 ) |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E |
-0.352 (Sector) 42.63 (Industry) 24.32 |
ATR14 | $0.105 (7.09%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2023-06-01 | Tang Kevin C | Sell | 4 394 800 | Common Stock |
2023-06-01 | Ubs Oncology Impact Fund L.p. | Sell | 3 370 982 | Common Stock |
2023-06-01 | Mpm Sunstates Fund, L.p. | Sell | 4 158 964 | Common Stock |
2023-06-01 | Mpm Bioventures 2014, L.p. | Sell | 4 158 964 | Common Stock |
2023-06-01 | Gadicke Ansbert | Sell | 3 370 982 | Common Stock |
INSIDER POWER |
---|
-90.05 |
Last 99 transactions |
Buy: 1 629 400 | Sell: 23 030 678 |
Wolumen Korelacja
TCR2 Therapeutics Inc Korelacja
10 Najbardziej pozytywne korelacje |
---|
10 Najbardziej negatywne korelacje |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
TCR2 Therapeutics Inc Korelacja - Waluta/Towar
TCR2 Therapeutics Inc Finanse
Annual | 2022 |
Przychody: | $0 |
Zysk brutto: | $0 (0.00 %) |
EPS: | $-3.93 |
FY | 2022 |
Przychody: | $0 |
Zysk brutto: | $0 (0.00 %) |
EPS: | $-3.93 |
FY | 2021 |
Przychody: | $0.00 |
Zysk brutto: | $0.00 (0.00 %) |
EPS: | $-3.57 |
FY | 2020 |
Przychody: | $0.00 |
Zysk brutto: | $0.00 (0.00 %) |
EPS: | $-2.40 |
Financial Reports:
No articles found.
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
TCR2 Therapeutics Inc
TCR2 Therapeutics Inc., a clinical-stage immunotherapy company, focuses on developing novel T cell receptor (TCR) therapies for patients suffering from cancer. The company's lead product candidates include gavo-cel, a mono TCR Fusion Construct T cells (TRuC-T cells) targeting mesothelin positive solid tumors, which is in phase I/II clinical trial for the treatment of non-small cell lung cancer (NSCLC), ovarian cancer, malignant pleural/peritoneal mesothelioma, and cholangiocarcinoma. It is also developing TC-510, a mesothelin-targeted TRuC-T cell that has completed preclinical trials to treat solid tumors; and TC-520, a fratricide resistant CD70 targeting TRuC-T cell for the treatment of renal cell carcinoma. The company was formerly known as TCR2, Inc. and changed its name to TCR2 Therapeutics Inc. in November 2016. TCR2 Therapeutics Inc. was incorporated in 2015 and is headquartered in Cambridge, Massachusetts.
O Sygnały na żywo
Prezentowane na tej stronie sygnały na żywo pomagają określić, kiedy KUPIĆ lub SPRZEDAĆ BRAK DANYCH. Sygnały mogą mieć opóźnienie wynoszące nawet 1 minutę; jak wszystkie sygnały rynkowe, istnieje ryzyko błędu lub pomyłki.
Sygnały transakcyjne na żywo nie są ostateczne i getagraph.com nie ponosi odpowiedzialności za żadne działania podjęte na podstawie tych sygnałów, jak opisano w Warunkach Użytkowania. Sygnały opierają się na szerokim zakresie wskaźników analizy technicznej